Registration Document Including The Annual Financial Report

Overview

The report describes Transgene's 2016 restructuring and refocusing on research and development, including the outsourcing of bio-manufacturing. It highlights two clinical collaboration agreements involving its immunotherapies and immune checkpoint inhibitors. Financially, the company secured a €20 million European Investment Bank loan and completed a €46.4 million rights issue. Its CSR disclosures report 3,104 m3 of water use and 3,902,541 kWh of electricity consumption.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Publication date: 13 April 2017
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services